Esther Lee - Dec 30, 2022 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
Director
Signature
By Cheryl Brice, Attorney-in-Fact for
Stock symbol
CLX
Transactions as of
Dec 30, 2022
Transactions value $
$0
Form type
4
Date filed
1/4/2023, 04:08 PM
Previous filing
Jan 4, 2022
Next filing
Jan 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Deferred Stock Units +Grant/Award $0 +75 +0.81% $0.00 9,359 Feb 11, 2022 Common Stock 75 Direct F1, F2, F3
transaction CLX Deferred Stock Units +Grant/Award $0 +69 +0.73% $0.00 9,428 May 13, 2022 Common Stock 69 Direct F1, F2, F3
transaction CLX Deferred Stock Units +Grant/Award $0 +76 +0.81% $0.00 9,504 Aug 12, 2022 Common Stock 76 Direct F1, F2, F3
transaction CLX Deferred Stock Units +Grant/Award $0 +78 +0.82% $0.00 9,581 Nov 10, 2022 Common Stock 78 Direct F1, F2, F3
transaction CLX Deferred Stock Units +Grant/Award $0 +1,073 +11.2% $0.00 10,655 Dec 30, 2022 Common Stock 1,073 Direct F1, F3, F4

Explanation of Responses:

Id Content
F1 1-for-1
F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4 Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.